Integrin α1β1 is involved in the differentiation into myofibroblasts in adult reactive tissues in vivo

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 3449-3462

  Rodriguez, Alejandro ^a   Karen, Jakob ^a   Gardner, Humphrey ^b   Gerdin, Bengt ^c   Rubin, Kristofer ^a   Sundberg, Christian ^a,d  

^a UPPSALA UNIVERSITY   (Sweden)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Adenocarcinoma rheumatoid arthritis; Integrin connective tissue; Matrigel; Myofibroblast; Pericyte

Indexed keywords

MUS;

COLLAGEN; LAMININ; MATRIGEL; PROTEOGLYCAN; VERY LATE ACTIVATION ANTIGEN 1;

ADENOCARCINOMA; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOPSY; CANCER TRANSPLANTATION; CARCINOMA; CELL DIFFERENTIATION; CHEMISTRY; COLON; COLORECTAL TUMOR; CYTOLOGY; DRUG COMBINATION; HUMAN; METABOLISM; MOUSE; MYOFIBROBLAST; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PERICYTE; RHEUMATOID ARTHRITIS; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; ARTHRITIS, RHEUMATOID; BIOPSY; CARCINOMA; CELL DIFFERENTIATION; CELL LINE, TUMOR; COLLAGEN; COLON; COLORECTAL NEOPLASMS; DRUG COMBINATIONS; HUMANS; INTEGRIN ALPHA1BETA1; LAMININ; MICE; MICE, INBRED BALB C; MYOFIBROBLASTS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; PROTEOGLYCANS;

EID: 77449136273     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00638.x     Document Type: Article

References (62)

1. Barsky SH, Green WR, Grotendorst GR. Desmoplastic breast carcinoma as a source of human myofibroblasts. Am J Pathol. 1984, 115:329-33.
2. Hewitt RE, Powe DG, Carter GI. Desmoplasia and its relevance to colorectal tumour invasion. Int J Cancer. 1993, 53:62-9.
3. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995, 1:27-31.
4. Dvorak HF. Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing. N Engl J Med. 1986, 315:1650-5.
5. Gabbiani F. Interpolating between cellular biophysics and computation in single neurons. Neuron. 2003, 37:890-1.
6. Wynn TA. Fibrotic disease and the TH1/TH2 paradigm. Nat Rev Immunol. 2004, 4:583-94.
7. Yang GP, Lim IJ, Phan TT. From scarless fetal wounds to keloids: molecular studies in wound healing. Wound Repair Regen. 2003, 11:411-8.
8. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007, 127:526-37.
9. Gabbiani G. Evolution and clinical implications of the myofibroblast concept. Cardiovasc Res. 1998, 38:545-8.
10. Ronnov-Jessen L, Petersen OW, Koteliansky VE. The origin of myofibroblasts in breast cancer. J Clin Invest. 1995, 95:859-73.
11. Sundberg C, Ivarsson M, Gerdin B. Pericytes as collagen producing cells in excessive dermal scarring. Lab Invest. 1996, 74:452-66.
12. Sundberg C, Kowanetz M, Brown LF. Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo. Lab Invest. 2002, 82:387-401.
13. Ivarsson M, Sundberg C, Farrokhnia N. Recruitment of type I collagen producing cells from the microvasculature in vitro. Exp Cell Res. 1996, 229:336-49.
14. Desmouliere A, Guyot C, Gabbiani G. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol. 2004, 48:509-17.
15. Hinz B, Gabbiani G. Cell-matrix and cell-cell contacts of myofibroblasts: role in connective tissue remodeling. Thromb Haemost. 2003, 90:993-1002.
16. Welch MP, Odland GF, Clark RA. Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol. 1990, 110:133-45.
17. Munger JS, Huang X, Kawakatsu H. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999, 96:319-28.
18. Scaffidi AK, Moodley YP, Weichselbaum M. Regulation of human lung fibroblast phenotype and function by vitronectin and vitronectin integrins. J Cell Sci. 2001, 114:3507-16.
19. Ng CP, Hinz B, Swartz MA. Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro. J Cell Sci. 2005, 118:4731-9.
20. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol. 1990, 8:365-400.
21. Wayner EA, Carter WG. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta-subunits. J Cell Biol. 1987, 105:1873-84.
22. Gardner H, Kreidberg J, Koteliansky V. Deletion of integrin [alpha]1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion. Dev Biol. 1996, 175:301-13.
23. Levine JM, Nishiyama A. The NG2 chondroitin sulfate proteoglycan: a multifunctional proteoglycan associated with immature cells. Perspect Dev Neurobiol. 1996, 3:245-59.
24. Skalli O, Ropraz P, Trzeciak A. A monoclonal antibody against alpha smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol. 1986, 103:2787-96.
25. Nehls V, Drenckhahn D. Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin. J Cell Biol. 1991, 113:147-54.
26. Sundberg C, Ljungstrom M, Lindmark G. Microvascular pericytes express platelet-derived growth factor-beta receptors in human healing wounds and colorectal adenocarcinoma. Am J Pathol. 1993, 143:1377-88.
27. Van Muijen GN, Ruiter DJ, Warnaar SO. Coexpression of intermediate filament polypeptides in human fetal and adult tissues. Lab Invest. 1987, 57:359-69.
28. Saalbach A, Anderegg U, Bruns M. Novel fibroblast-specific monoclonal antibodies: properties and specificities. J Invest Dermatol. 1996, 106:1314-9.
29. Ziai MR, Imberti L, Nicotra MR. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight-melanoma associated antigen. Cancer Res. 1987, 47:2474-80.
30. Schlingemann RO, Rietveld FJR, de Waal RMW. Expression of the high molecular weight-melanoma associated antigen by pericytes during angiogenesis in tumors and in healing wounds. Am J Pathol. 1990, 136:1393-405.
31. MacDonald JA, Broekelmann TJ, Matheke ML. A monoclonal antibody to the carboxyterminal domain of procollagen type I visualizes collagen-synthesizing fibroblasts: detection of an altered fibroblast phenotype in lungs of patients with pulmonary fibrosis. J Clin Invest. 1986, 78:1237-44.
32. Tingström A, Reuterdahl C, Lindahl P. Expression of platelet-derived growth factor beta-receptors on human fibroblasts: regulation by recombinant platelet-derived growth factor-BB, IL-1 and tumor necrosis factor-alpha. J Immunol. 1992, 148:546-54.
33. Wayner EA, Carter WG, Piotrowicz RS. The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoprotein Ic-IIa. J Cell Biol. 1988, 107:1881-91.
34. Sonnenberg A, Modderman PW, Hogervorst F. Laminin receptor on platelets is the integrin VLA-6. Nature. 1988, 336:487-9.
35. Sundberg C, Branting M, Gerdin B. Tumor cell and connective tissue cell interactions in human colorectal adenocarcinoma. Transfer of platelet-derived growth factor-AB/BB to stromal cells. Am J Pathol. 1997, 151:479-92.
36. Goepfert C, Sundberg C, Sevigny J. Disordered extracellular nucleotide-mediated cellular responses perturb angiogenesis in cd39-null mice. Circulation. 2001, 104:3109-15.
37. Pozzi A, LeVine WF, Gardner HA. Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis. Oncogene. 2002, 21:272-81.
38. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol. 2003, 200:500-3.
39. Sappino AP, Schurch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest. 1990, 63:144-61.
40. Skalli O, Schurch W, Seemayer T. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest. 1989, 60:275-85.
41. Tuchweber B, Desmouliere A, Bochaton-Piallat ML. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest. 1996, 74:265-78.
42. Kinnman N, Francoz C, Barbu V. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest. 2003, 83:163-73.
43. Shao ZM, Nguyen M, Barsky SH. Human breast carcinoma desmoplasia is PDGF initiated. Oncogene. 2000, 19:4337-45.
44. Reuterdahl C, Sundberg C, Funa K. Tissue localization of beta-receptors for platelet-derived growth factor and platelet-derived growth factor B-chain during wound repair in humans. J Clin Invest. 1993, 91:2065-75.
45. Reuterdahl C, Tingström A, Terracio L. Characterization of PDGF beta-receptor expressing cells in the vasculature of the rheumatoid synovium. Lab Invest. 1991, 64:321-9.
46. Crocker DJ, Murad TM, Geer JP. The role of the pericyte in wound healing. An ultrastructural study. Exp Mol Pathol. 1970, 51-65.
47. Rhodin JAG, Fujita H. Capillary growth in the mesentry of normal young rats. Intravital video and electron microscope analysis. J Submicrosc Cytol Pathol. 1989, 21:1-34.
48. Dore-Duffy P, Owen C, Balabanov R. Pericyte migration from the vascular wall in response to traumatic brain injury. Microvasc Res. 2000, 60:55-69.
49. Ausprunk P, Folkman J. Migration and proliferation of endothelial cells in preformed and newly-formed blood vessels during tumor angiogenesis. Microvasc Res. 1977, 14:53-65.
50. Lindahl P, Betsholtz C. Not all myofibroblasts are alike: revisiting the role of PDGF-A and PDGF-B using PDGF-targeted mice. Curr Opin Nephrol Hypertens. 1998, 7:21-6.
51. Crosby JR, Tappan KA, Seifert RA. Chimeric analysis reveals that fibroblasts and endothelial cells require platelet-derived growth factor receptor beta-expression for participation in reactive connective tissue formation in adults but not during development. Am J Pathol. 1999, 154:1315-21.
52. Senger DR, Claffey KP, Benes JE. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci USA. 1997, 94:13612-7.
53. Senger DR, Perruzzi CA, Streit M. The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am J Pathol. 2002, 160:195-204.
54. Pozzi A, Moberg PE, Miles LA. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci USA. 2000, 97:2202-7.
55. Holash J, Wiegand SJ, Yancopoulos GD. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene. 1999, 18:5356-62.
56. Shephard P, Martin G, Smola-Hess S. Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. Am J Pathol. 2004, 164:2055-66.
57. Orlidge A, D'Amore PA. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol. 1987, 1455-62.
58. Chen C, Sheppard D. Identification and molecular characterization of multiple phenotypes in integrin knockout mice. Methods Enzymol. 2007, 426:291-305.
59. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002, 110:673-87.
60. Hynes RO. Cell-matrix adhesion in vascular development. J Thromb Haemost. 2007, 5 Suppl 1:32-40.
61. Reynolds AR, Reynolds LE, Nagel TE. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice. Cancer Res. 2004, 64:8643-50.
62. Diaz-Gonzalez F, Forsyth J, Steiner B. Trans-dominant inhibition of integrin function. Mol Biol Cell. 1996, 7:1939-51.